Paradigm Biopharmaceuticals Ltd (PAR) — Long-term Investment Intensity
Paradigm Biopharmaceuticals Ltd (PAR) has a Long-term Investment Intensity of 0.1% as of June 2021. Long-term investments of AU$102.62K represent 0.1% of total assets of AU$84.79 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore PAR cash flow conversion to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Paradigm Biopharmaceuticals Ltd Long-term Investment Intensity (2020–2021)
This chart shows how Paradigm Biopharmaceuticals Ltd's Long-term Investment Intensity has evolved across 2 annual periods from 2020 to 2021. As of June 2021, the intensity stands at 0.1%, reflecting long-term investments of AU$102.62K against total assets of AU$84.79 Million AUD. Explore Paradigm Biopharmaceuticals Ltd (PAR) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Paradigm Biopharmaceuticals Ltd (2020–2021)
The table below presents the year-by-year Long-term Investment Intensity for Paradigm Biopharmaceuticals Ltd from 2020 to 2021, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see how much is Paradigm Biopharmaceuticals Ltd worth.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.1% | AU$102.62K | AU$84.79 Million | ▲ +0.0 pp |
| 2020 | 0.1% | AU$102.62K | AU$112.36 Million | — |